AnPac Bio-Medical Science Co., Ltd. — Form D

AnPac Bio-Medical Science Co., Ltd. of Lishui, F4, a company, filed a Form D exempt-offering notice with the SEC on 2022-06-13. The offering totals $1.5M, of which $1.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (21)

NameRoleLocation
Aidong ChenDirectorLishui, F4
Feng GuoDirectorLishui, F4
Sheng LiuDirectorLishui, F4
Ren LuoDirectorLishui, F4
Jianhua ShaoDirectorLishui, F4
Pu XingDirectorLishui, F4
Chris Chang YuDirectorLishui, F4
Aidong ChenExecutive OfficerLishui, F4
Weidong DaiExecutive OfficerLishui, F4
XueDong DuExecutive OfficerLishui, F4
Jinqiu TangExecutive OfficerLishui, F4
Chris Chang YuExecutive OfficerLishui, F4
He YuExecutive OfficerLishui, F4
Lin YuDirectorIrvine, CA
Edward TangExecutive OfficerSan Mateo, CA
Chang YuDirectorLishui, F4
Chang YuExecutive OfficerLishui, F4
Sarah YuDirectorLishui, F4
Jiefeng GuExecutive OfficerLishui, F4
Yu ChrisDirectorLishui, F4
Yu ChrisExecutive OfficerLishui, F4

Other filings by this issuer (3)

FiledFormOfferingSold
2022-06-13D$1.5M$1.5M
2022-05-27D$1.4M$1.4M
2020-08-24D$265K$265K

More